Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 7;13(12):1195.
doi: 10.3390/antibiotics13121195.

Evaluation of a Pharmacist-Led Methicillin-Resistant Staphylococcus aureus Nasal PCR Testing Protocol

Blain Thayer  1 , Jonathan D Edwards  2 , Madeline G Belk  2 , Spencer H Durham  3
Affiliations

Evaluation of a Pharmacist-Led Methicillin-Resistant Staphylococcus aureus Nasal PCR Testing Protocol

Blain Thayer et al. Antibiotics (Basel). .

Abstract

Background/Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) can cause cases of community-acquired pneumonia, hospital-acquired pneumonia, and ventilator-associated pneumonia, and nasal colonization with this pathogen increases the risk of infection. Due to its high negative predictive value, multiple studies support using the MRSA nasal polymerase chain reaction (PCR) test to discontinue antimicrobials that target MRSA in the setting of a negative test result. The purpose of this project was to assess the utility of a protocol to allow pharmacists the ability to order MRSA nasal PCR screenings in hospitalized patients with pneumonia. Results: The pre-protocol group included a random sample of 100 patients, and the post-protocol group included 625 patients. Vancomycin DOTs when pharmacists ordered PCRs were significantly lower compared to the pre-protocol group (p < 0.5; 95% CI, 0.46-2.24). The average length of stay and readmission rates at 30 days were significantly lower in the post-protocol group compared to the pre-protocol group (p < 0.05 and p = 0.02, respectively), but there was no significant difference in mortality (p = 0.33). Methods: A protocol was implemented at our institution that allowed pharmacists to order an MRSA nasal PCR test in patients with pneumonia. This retrospective chart review compared a cohort of patients who received vancomycin from before implementation of the protocol to patients who received vancomycin after the protocol's implementation. The primary endpoint was vancomycin days of therapy (DOTs) between the pre-protocol group and the post-protocol group. Other endpoints assessed included the length of hospitalization, readmission rates, and mortality. Conclusions: Pharmacists ordering MRSA nasal PCR tests significantly reduced vancomycin DOTs, average length of stay, and 30-day readmission rates, contributing to positive outcomes in patients with pneumonia.

Keywords: antimicrobial stewardship; methicillin-resistant Staphylococcus aureus; pneumonia; polymerase chain reaction; vancomycin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Vancomycin days of therapy—pre-protocol vs. post-protocol pharmacist-ordered PCRs.
Figure 2
Figure 2
Pharmacist survey results.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Rubinstein E., Kollef M.H., Nathwani D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 2008;46((Suppl. S5)):S378–S385. doi: 10.1086/533594. - DOI - PubMed
    1. Pickens C.I., Wunderink R.G. Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia. Semin. Respir. Crit. Care Med. 2022;43:304–309. doi: 10.1055/s-0041-1740583. - DOI - PMC - PubMed
    1. Lewis S.S., Walker V.J., Lee M.S., Chen L., Moehring R.W., Cox C.E., Sexton D.J., Anderson D.J. Epidemiology of methicillin-resistant Staphylococcus aureus pneumonia in community hospitals. Infect. Control. Hosp. Epidemiol. 2014;35:1452–1457. doi: 10.1086/678594. - DOI - PMC - PubMed
    1. Keene A., Vavagiakis P., Lee M.H., Finnerty K., Nicolls D., Cespedes C., Quagliarello B., Chiasson M.A., Chong D., Lowy F.D. Staphylococcus aureus colonization and the risk of infection in critically ill patients. Infect. Control. Hosp. Epidemiol. 2005;26:622–628. doi: 10.1086/502591. - DOI - PubMed
    1. Ridgway J.P., Peterson L.R., Brown E.C., Du H., Hebert C., Thomson R.B., Jr., Kaul K.L., Robicsek A. Clinical significance of methicillin-resistant Staphylococcus aureus colonization on hospital admission: One-year infection risk. PLoS ONE. 2013;8:e79716. doi: 10.1371/journal.pone.0079716. - DOI - PMC - PubMed

LinkOut - more resources